CYTOSORBENTS CORPORATION
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $62.6M | $52.1M |
| FY2022 | $5.0M | $35.4M | $22.1M |
| FY2023 | $2.5M | $29.9M | $14.1M |
| FY2024 | $14.0M | $19.6M | $3.3M |
| FY2025 | $16.7M | $5.9M | $6.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $62.6M | $52.1M |
| FY2022 | $5.0M | $35.4M | $22.1M |
| FY2023 | $2.5M | $29.9M | $14.1M |
| FY2024 | $14.0M | $19.6M | $3.3M |
| FY2025 | $16.7M | $5.9M | $6.2M |